NATALIE KING: Open Payments
NPI 1396122735 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 92 payments from 20 companies in 2025. Trend: 2023 $1,543 · 2024 $1,700 · 2025 $1,646
Food & beverage: $1,646
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $302 |
| Corcept Therapeutics | 14 | $216 |
| Tandem Diabetes Care, Inc. | 12 | $187 |
| Sequel Med Tech, LLC | 4 | $156 |
| Lilly USA, LLC | 8 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $114 |
| Xeris Pharmaceuticals, Inc. | 5 | $103 |
| Abbott Laboratories | 5 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| CeQur Corporation | 1 | $58 |
Products named: Korlym, t:slim X2 Insulin Pump with Control-IQ, Ozempic, TWIIST, JARDIANCE, Wegovy, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across IN — which companies pay providers there.
